These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37999650)

  • 21. Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.
    Rapinesi C; Kotzalidis GD; Mazzarini L; Brugnoli R; Ferracuti S; De Filippis S; Cuomo I; Giordano G; Del Casale A; Angeletti G; Sani G; Girardi P
    Clin Drug Investig; 2019 Aug; 39(8):713-735. PubMed ID: 31152368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents.
    Aggarwal A; Gopalakrishna G; Lauriello J
    Clin Schizophr Relat Psychoses; 2016; 10(1):58-63. PubMed ID: 27074333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole.
    Shymko G; Dobson L; Acacio MC; Grace T; Tadier S; Waters F
    Schizophr Res; 2023 Jan; 251():74-81. PubMed ID: 36587541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiation of aripiprazole once-monthly in patients with schizophrenia.
    Raoufinia A; Baker RA; Eramo A; Nylander AG; Landsberg W; Kostic D; Larsen F
    Curr Med Res Opin; 2015 Mar; 31(3):583-92. PubMed ID: 25586294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.
    Fagiolini A; Alfonsi E; Amodeo G; Cenci M; Di Lella M; Farinella F; Ferraiuolo F; Fraguas D; Loparco N; Gutierrez-Rojas L; Mignone ML; Pataracchia G; Pillai G; Russo F; Sanchez-Gistau V; Spinogatti F; Toscano M; Villari V; De Filippis S
    Expert Opin Drug Saf; 2016; 15(4):449-55. PubMed ID: 26886162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report.
    Eum S; Schneiderhan ME; Brown JT; Lee AM; Bishop JR
    BMC Psychiatry; 2017 Jul; 17(1):238. PubMed ID: 28673279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.
    Hebbrecht K; Morrens M; Neels H; Roosens L; Sabbe BGC
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):999-1005. PubMed ID: 30141352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole IM depot as an option for the treatment of bipolar disorder.
    Kotzalidis GD; Rapinesi C; Chetoni C; De Filippis S
    Expert Opin Pharmacother; 2021 Aug; 22(11):1407-1416. PubMed ID: 33847183
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications.
    Citrome L
    Expert Rev Neurother; 2017 Oct; 17(10):1029-1043. PubMed ID: 28832262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.
    Jann MW; Penzak SR
    CNS Drugs; 2018 Mar; 32(3):241-257. PubMed ID: 29569082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study.
    Cai Q; Patel C; Kim E; Connolly N; Tunceli O; El Khoury AC
    Adv Ther; 2019 Apr; 36(4):858-869. PubMed ID: 30848442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Predictors of Discontinuation of Aripiprazole Long-acting Injection: A 12-Month Naturalistic Cohort Study.
    Aftab R; Pereira M; Hewitt J; Whale R
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):478-483. PubMed ID: 34155164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis.
    Kane JM; Zhao C; Johnson BR; Baker RA; Eramo A; McQuade RD; Duca AR; Sanchez R; Peters-Strickland T
    J Med Econ; 2015 Feb; 18(2):145-54. PubMed ID: 25347448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole LAI two-injection start in a 16 year-old adolescent with schizophrenia.
    Salvi V; Appignanesi C; Marpepa B; Orsolini L; Volpe U
    Neuropsychopharmacol Rep; 2022 Jun; 42(2):241-244. PubMed ID: 35182040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series.
    Moon E; Kim E; Williams A
    J Child Adolesc Psychopharmacol; 2023 Dec; 33(10):433-438. PubMed ID: 37910863
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly.
    Schöttle D; Wiedemann K; Correll CU; Janetzky W; Friede M; Jahn H; Brieden A
    Schizophr Res; 2023 Oct; 260():183-190. PubMed ID: 37683508
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland.
    Einarson TR; Pudas H; Goswami P; van Impe K; Bereza BG
    J Med Econ; 2016; 19(2):111-20. PubMed ID: 26414966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole Lauroxil NanoCrystal
    Ehret MJ; Davis E; Luttrell SE; Clark C
    Clin Schizophr Relat Psychoses; 2018; 12(2):92-96. PubMed ID: 30040476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.